Novel Therapies for the Treatment of Small-Cell Lung Cancer: A Time for Cautious Optimism?

Author： Board Ruth E. Thatcher Nick Lorigan Paul

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.15, 2006-01, pp. : 1919-1931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapies in small-cell lung cancer

By Fernainy Khaled Saba Nabil

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 8, 2007-08 ,pp. : 1033-1041

Informa Healthcare

Access to resources Recommend Favorite

Novel Systemic Therapies for Small Cell Lung Cancer

By Rudin Charles M. Hann Christine L. Peacock Craig D. Watkins D. Neil

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 315-322

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Resectable Non-Small Cell Lung Cancer in the Elderly: Is There a Role for Adjuvant Treatment?

By Langer Corey J.

Drugs & Aging, Vol. 25, Iss. 3, 2008-01 ,pp. : 209-218

Adis International

Access to resources Recommend Favorite

Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer

Current Drug Discovery Technologies, Vol. 6, Iss. 2, 2009-06 ,pp. : 91-102

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for small-cell lung cancer

By Metro Giulio Cappuzzo Federico

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 4, 2009-12 ,pp. : 591-606

Informa Healthcare

Access to resources Recommend Favorite